Unknown

Dataset Information

0

Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020.

ABSTRACT:

SUBMITTER: Chen S 

PROVIDER: S-EPMC7988366 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration.
| S-EPMC5817559 | biostudies-literature
Unknown ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.
| S-EPMC5028264 | biostudies-literature
Unknown Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997.
| S-EPMC7780607 | biostudies-literature
Unknown Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs.
| S-EPMC7160417 | biostudies-literature
Unknown Initial American experience with hip resurfacing following FDA approval.
| S-EPMC2600981 | biostudies-other
Unknown 5-ALA and FDA approval for glioma surgery.
| S-EPMC6445645 | biostudies-literature
Unknown Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020.
| S-EPMC8616766 | biostudies-literature
Unknown FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.
| S-EPMC4142419 | biostudies-literature
Unknown Timelines of translational science: From technology initiation to FDA approval.
| S-EPMC5421779 | biostudies-literature
Unknown Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval.
| S-EPMC6784515 | biostudies-literature